muraglitazar has been researched along with glimepiride in 1 studies
| Studies (muraglitazar) | Trials (muraglitazar) | Recent Studies (post-2010) (muraglitazar) | Studies (glimepiride) | Trials (glimepiride) | Recent Studies (post-2010) (glimepiride) |
|---|---|---|---|---|---|
| 85 | 10 | 25 | 956 | 340 | 474 |
| Protein | Taxonomy | muraglitazar (IC50) | glimepiride (IC50) |
|---|---|---|---|
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | 6.39 | |
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.85 | |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 6.86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fiedorek, FT; Ledeine, JM; Rubin, CJ | 1 |
1 trial(s) available for muraglitazar and glimepiride
| Article | Year |
|---|---|
Improvement of glycaemic and lipid profiles with muraglitazar plus metformin in patients with type 2 diabetes: an active-control trial with glimepiride.
Topics: Administration, Oral; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Glycine; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Lipids; Male; Metformin; Middle Aged; Oxazoles; Sulfonylurea Compounds; Time Factors; Treatment Outcome | 2008 |